Table 1.

Single drug treatment against SARS-CoV-2 in vitro

Drug candidates	Drug class	Drug indication	CC50 (μM)	IC50 (μM) Plaque assay	IC50 (μM) qRT-PCR
Niclosamide	Anthelminthic agents	Treatment of tapeworm and intestinal fluke infections	0.29	0.049	0.043
Ivermectin	Anti-parasitic agents	Treatment of onchocerciasis, and other worm infestations	10.55	1.23	1.27
Chloroquine	Anti-malarial agents	Treatment of malaria, rheumatic diseases and Zika virus infection	118.20	0.83	0.89